acquired
Stage
1
Investors
About
Expedeon developed, manufactured, and commercialized proteomics reagents and tools for life science research, enabling advances in medical science and patient care through simplified and accelerated research processes.
Explore Expedeon's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.